Lv4
446 积分 2022-10-25 加入
TQC3721
11天前
已完结
Safety, pharmacokinetics and pharmacodynamics of TQC3721, an innovative, dual PDE3 and PDE4 inhibitor, in healthy subjects and patients with chronic obstructive pulmonary disease: Randomised, double-blind, placebo-controlled phase I and IIa clinical trials
11天前
已完结
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
12天前
已完结
The effect of fluconazole on the pharmacokinetics of ensifentrine in healthy individuals
17天前
已关闭
Ensifentrine: First Approval
18天前
已完结
Opportunities and Challenges of Hepatic Impairment Physiologically Based Pharmacokinetic Modeling in Drug Development—An IQ Perspective
1个月前
已完结
Plasma cysteine, cystine, and glutathione in cirrhosis
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Rocuronium in Patients with Cirrhosis
1个月前
已完结
Pharmacokinetics/pharmacodynamics of cisatracurium in healthy adult patients
1个月前
已完结
Pharmacokinetic/pharmacodynamic analysis of high‐dose tigecycline, by Monte Carlo simulation, in plasma and sputum of patients with hospital‐acquired pneumonia
3个月前
已完结
皖公网安备34019202002308
